Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Noninterventional Study of Vimpat® (Lacosamide) as Adjunctive Antiepileptic Drug Therapy in Patients With Brain Tumor-related Epilepsy

NCT02276053 is registered in ClinicalTrials.gov with UCB BIOSCIENCES GmbH as lead sponsor.

NCT NCT02276053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02276053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Noninterventional Study of Vimpat® (Lacosamide) as Adjunctive Antiepileptic Drug Therapy in Patients With Brain Tumor-related Epilepsy
Lead sponsor
UCB BIOSCIENCES GmbH
Phase
Observational
Overall status
Completed
Start date
November 27, 2014
Completion date
December 4, 2017
Enrollment
93 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor related epilepsy (btre)